LeMaitre Vascular Inc (LMAT) Insider David B. Roberts Sells 44,340 Shares

LeMaitre Vascular Inc (NASDAQ:LMAT) insider David B. Roberts sold 44,340 shares of the company’s stock in a transaction dated Thursday, May 4th. The shares were sold at an average price of $31.14, for a total transaction of $1,380,747.60. Following the sale, the insider now owns 46,945 shares of the company’s stock, valued at $1,461,867.30. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

LeMaitre Vascular (NASDAQ:LMAT) last released its quarterly earnings data on Thursday, May 4th. The medical instruments supplier reported $0.16 EPS for the quarter, beating analysts’ consensus estimates of $0.13 by $0.03. LeMaitre Vascular had a net margin of 12.19% and a return on equity of 12.83%. The company had revenue of $24.10 million during the quarter, compared to analyst estimates of $23.48 million. The firm’s revenue for the quarter was up 18.7% compared to the same quarter last year.

Insider Buying and Selling by Quarter for LeMaitre Vascular (NASDAQ:LMAT)

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 8th. Shareholders of record on Wednesday, May 24th will be given a dividend of $0.055 per share. The ex-dividend date is Monday, May 22nd. This represents a $0.22 annualized dividend and a yield of 0.73%. LeMaitre Vascular’s payout ratio is presently 32.73%.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally reported by Markets Daily and is the property of of Markets Daily. If you are reading this piece of content on another domain, it was stolen and republished in violation of international trademark and copyright laws. The original version of this piece of content can be accessed at https://www.themarketsdaily.com/2017/05/20/insider-selling-lemaitre-vascular-inc-lmat-insider-sells-1380747-60-in-stock-updated.html.

Several research firms recently weighed in on LMAT. Stifel Nicolaus increased their target price on shares of LeMaitre Vascular from $25.00 to $29.00 and gave the company a “buy” rating in a research note on Friday, April 28th. Canaccord Genuity reiterated a “buy” rating and issued a $28.00 target price on shares of LeMaitre Vascular in a research note on Thursday, April 27th. Zacks Investment Research upgraded shares of LeMaitre Vascular from a “hold” rating to a “buy” rating and set a $36.00 price target for the company in a research note on Friday, April 28th. Barrington Research cut shares of LeMaitre Vascular from an “outperform” rating to a “market perform” rating in a research note on Wednesday, February 22nd. Finally, First Analysis began coverage on shares of LeMaitre Vascular in a report on Tuesday, March 21st. They set an “overweight” rating and a $29.00 price objective for the company. Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $26.43.

Several large investors have recently made changes to their positions in the company. Martingale Asset Management L P raised its stake in shares of LeMaitre Vascular by 8.3% in the fourth quarter. Martingale Asset Management L P now owns 65,307 shares of the medical instruments supplier’s stock worth $1,655,000 after buying an additional 5,000 shares during the last quarter. Columbia Wanger Asset Management LLC raised its stake in shares of LeMaitre Vascular by 42.8% in the fourth quarter. Columbia Wanger Asset Management LLC now owns 904,295 shares of the medical instruments supplier’s stock worth $22,915,000 after buying an additional 271,167 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in shares of LeMaitre Vascular by 6.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 908,337 shares of the medical instruments supplier’s stock worth $23,017,000 after buying an additional 58,080 shares during the last quarter. State Street Corp raised its stake in shares of LeMaitre Vascular by 12.7% in the fourth quarter. State Street Corp now owns 329,877 shares of the medical instruments supplier’s stock worth $8,358,000 after buying an additional 37,142 shares during the last quarter. Finally, Bessemer Group Inc. raised its stake in shares of LeMaitre Vascular by 22.3% in the fourth quarter. Bessemer Group Inc. now owns 27,400 shares of the medical instruments supplier’s stock worth $694,000 after buying an additional 5,000 shares during the last quarter. Hedge funds and other institutional investors own 61.80% of the company’s stock.

LeMaitre Vascular Company Profile

LeMaitre Vascular, Inc is a provider of medical devices for the treatment of peripheral vascular disease. The Company develops, manufactures and markets medical devices and implants used primarily in the field of vascular surgery. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment.

12 Month Chart for NASDAQ:LMAT

Receive News & Ratings for LeMaitre Vascular Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LeMaitre Vascular Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply